Group Cognitive Hypnotherapy RCT | Research | Clear Minds

When most people think of hypnotherapy, they picture a one-to-one session — a therapist, a reclining chair, and a quiet room. But a growing body of evidence is challenging that image. A recent randomised clinical trial tested what happens when hypnotherapy is delivered in a group format — and the results went beyond reducing anxious thoughts. Researchers measured actual changes in stress hormones.

Here is what the study found, why it matters, and how it connects to the kind of support available through Clear Minds.

The Study: Group Cognitive Hypnotherapy vs Standard Care for Anxiety

The randomised controlled trial, published in 2025, recruited patients diagnosed with an anxiety disorder and divided them into two conditions: one group received group-based cognitive hypnotherapy (GBCH), the other continued with standard medical care.

What made this study stand out was its measurement approach. Rather than relying solely on self-reported anxiety scales, the researchers also collected blood samples to track neuroendocrine markers — specifically cortisol and related stress hormones — before and after the intervention. This meant the researchers could evaluate not just how patients felt, but what was happening inside their bodies.

The GBCH sessions combined cognitive restructuring techniques with guided hypnotic induction, delivered in a shared group setting over several weeks. Participants worked through anxiety triggers, learnt relaxation protocols, and practised entering a focused hypnotic state together.

What the Findings Showed

The results were significant on both fronts:

• Somatic symptoms — physical manifestations of anxiety such as muscle tension, rapid heartbeat, and fatigue — showed meaningful reduction in the GBCH group compared to those receiving standard care.
• Anxiety severity scores improved substantially, with participants reporting lower levels of generalised worry, rumination, and anxious avoidance.
• Most strikingly, neuroendocrine markers including cortisol showed measurable decreases in the hypnotherapy group, suggesting that the intervention was producing genuine physiological change — not just a placebo response.

The group setting also showed an unexpected benefit: participants reported feeling less isolated in their struggles, which itself appeared to reinforce the therapeutic gains.

Why Measuring Stress Hormones Matters

Cortisol is the body's primary stress hormone. When anxiety becomes chronic, cortisol levels can remain persistently elevated — disrupting sleep, weakening immune function, affecting digestion, and increasing risk of cardiovascular issues over time. The fact that hypnotherapy moved these biomarkers, not just mood ratings, is clinically significant.

It adds to a growing body of research showing that hypnotherapy does not work through suggestion alone. It appears to shift the physiological underpinnings of the stress response — calming the nervous system at a biological level, not merely at a conscious one.

Previous studies have shown that hypnosis alters activity in the anterior cingulate cortex (the brain's centre for attention and pain modulation) and reduces activity in the default mode network, which governs self-referential thinking and rumination. This 2025 trial adds hormonal evidence to the brain imaging picture.

The Case for Group Hypnotherapy

Another dimension of this research is its implications for access. Individual hypnotherapy sessions with a qualified therapist can be expensive and logistically demanding. Group formats, whether in-person or via app-based guided audio, can deliver comparable outcomes at significantly lower cost and with greater flexibility.

A meta-analysis of 67 studies examining group vs individual therapy for anxiety disorders found no statistically significant difference in outcomes between the two formats. This trial adds hypnotherapy to that picture — suggesting that the quality of the intervention matters more than the setting in which it is delivered.

For people who feel they cannot afford or access traditional one-on-one hypnotherapy, this is meaningful news.

What This Means in Practice

Anxiety disorders affect roughly one in six adults in the UK. Despite this, many people go untreated, either because they cannot access talking therapies quickly enough through the NHS or because private therapy feels out of reach. Hypnotherapy delivered digitally — through structured audio programmes — represents one of the most scalable responses to that gap.

The 2025 RCT supports the idea that hypnotherapy's mechanism is robust enough to work across different formats. The shift in cortisol, the reduction in somatic symptoms, the measurable anxiety relief — these did not require a one-to-one appointment. They happened through structured, guided hypnotic work applied consistently.

That is precisely the model Clear Minds is built on: evidence-based hypnotherapy, delivered in a format anyone can access — on their phone, at their own pace, wherever they are.

Key Takeaways from This Research

• A 2025 RCT found that group cognitive hypnotherapy significantly reduced anxiety symptoms compared to standard care.
• Participants also showed measurable reductions in cortisol and other neuroendocrine stress markers — indicating real biological change, not just psychological reporting.
• Group-format hypnotherapy is effective, making evidence-based treatment more accessible and scalable.
• These findings support the use of app-based hypnotherapy as a clinically credible intervention for anxiety.
• Hypnotherapy appears to work through genuine neurological and hormonal mechanisms, not merely through placebo effect.

As research into hypnotherapy continues to mature, studies like this one are helping shift it from the fringes into the mainstream of mental health care — and providing a solid scientific foundation for the millions of people seeking a calmer, more grounded way to live.